MEF2A sequence variants and coronary artery disease: A change of heart?

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 831-833

  Altshuler, David ^a,b,c   Hirschhorn, Joel N ^a,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYOCYTE ENHANCER FACTOR 2;

CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MEF2A GENE; MISSENSE MUTATION; PRIORITY JOURNAL; REVIEW;

EID: 16844382494     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24715     Document Type: Review

References (15)

1. Lusis, A.J., Mar, R, and Pajukanta, P. 2004. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 5:189-218.
2. Wang, L., Fan, C., Topol, S.E., Topol, E.J., and Wang, Q. 2003. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 302:1578-1581.
3. Weng, L., et al. 2005. Lack of MEF2A mutations in coronary arterydisease. J. Clin. Invest. 115:1016-1020. doi:10.1172/JCI200524186.
4. Bhagavatula, M.R., et al. 2004. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 13:3181-3188.
5. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L., and Rothman, N. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96:434-442.
6. Lohmueller, K., Pearce, C.L., Pike, M., Lander, E.S., and Hirschhorn, J.N. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33:177-182.
7. Hirschhorn, J.N., and Altshuler, D. 2002. Once and again-issues surrounding replication in genetic association studies. J. Clin. Endocrinol. Metab. 87:4438-4441.
8. Dahlman, I., et al. 2002. Parameters for reliable results in genetic association studies in common disease. Nat. Genet. 30:149-150.
9. Florez, J.C., Hirschhorn, J., and Altshuler, D. 2003. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics Hum. Genet. 4:257-291.
10. Lifton, R.P., Gharavi, A.G., and Geller, D.S. 2001. Molecular mechanisms of human hypertension. Cell. 104:545-556.
11. Wang, Q., et al. 2004. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74:262-271.
12. Pajukanta, P., et al. 2000. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67:1481-1493.
13. Hauser, E.R., et al. 2004. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75:436-447.
14. Francke, S., et al. 2001. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 10:2751-2765.
15. Broeckel, U., et al. 2002. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30:210-214.